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1. Introduction 
The final reactions in the biosynthesis of thiamine, 
as described by several research groups, include (1) a 
two-step yrophosphorylation of 2-methyl4amino- 
S-hydroxymethyl-pyriidine (pyrimidine moiety of 
thiamine), (2) a phosphorylation of 4-methyl-5.(2- 
hydroxymethyl)thiazole (thiazole moiety of thiamine), 
(3) condensation of the two parts to thiamine mono- 
phosphate and, finally, its dephosphorylation [l] . 
Little is known, however, about the biosynthesis of 
the pyrimidine and thiazole moieties of thiamine. The 
pathway leading to the pyrimidine moiety separates 
from that of the purines on the level of 4-amino- 
imidazole ribonucleotide [2] . 
Three years ago, a collection of 21 mutants of 
Saccharomyces cerevisiae in the biosynthesis of the 
pyrimidine moiety of thiamine could be divided into 
two groups. With three exceptions, each individual of 
a group of 14 mutants (P2-mutants) fed each of a 
group of 7 (Pl-) mutants, but not vice versa [3] . 
Recently, it has been possible to isolate and charac- 
terize a substance which accumulates inP2-mutant 
cells grown under limiting amounts of thiamine. This 
substance meets the growth requirements of a Pl- 
mutant. 
Its UV spectrum exhibits a maximum at 259 nm. 
This intermediate will be referred to as “compound 
259” throughout his paper. 
2. A biological assay for “compound 259” 
A 0.03 ml sample from each fraction of the chro- 
matogram was mixed with 5 ml minimal medium [4] 
North-Holland Publishing Company - Amsterdam 
and neutralized if necessary. About lo7 carefully 
washed cells of the S. cerevisiae mutant HK 354 (PI- 
mutant) were then added to the autoclaved supple- 
mented medium. Growth was checked turbidimetri- 
tally after 72 hr at 30”. 
3. Preparation of “compound 259” 
The mutant HK 210 of S. cerevisiae (P2-mutant) 
was grown in minimal medium [4] supplemented with 
(3.008 mg thiamine hydrochloride/l. After overnight 
incubation at 30’) the cells were harvested by centri- 
fugation and suspended inminimal medium supple- 
mented with (all 1 mM) glycine, sodium formate, glu- 
tamine, &alanine, sodium acetate, methionine and as- 
partic acid. Glycine, formate and glutamate are known 
to be needed for the biosynthesis of 4-amino-imidazole 
ribonucleotide, the last common intermediate of the 
purine pathway and the pyrimidine moiety pathway 
[5] . &Alanine etc. are possible canditates for precur- 
sor compounds in the biosynthesis of the pyrimidine 
moiety [2,6-g]. 
After 15 hr at 30”) the cells were pelleted and the 
medium was passed through a column of granulated 
charcoal. The loaded column was washed with distilled 
water. “Compound 259” was then eluted with an 
ethanol-water mixture (1: 1, v/v), the eluted solution 
was evaporated to dryness and the residue was dis- 
solved in 0.5 N ammonia nd applied to a column of 
Sephadex G-10 (2.5 X 96 cm). The thiamine precursor 
compound was eluted with 0.5 M ammonia. A distinct 
peak (II) was found to be associated with the biologi- 
cally active compound (fig. 1). The fractions compris- 
ing this peak were again subjected to gel chromato- 
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Fig. 1 and 2. Gel chromatography of “compound 259” on Sephadex G-10 with 0.5 N ammonia and 0.5 N acetic acid, respectively. 
graphy on a column of Sephadex G-10 (2.5 X 96 cm) 
with 0.5 N acetic acid. The most prominent ultraviolet 
light absorbing peak in this fractionation corresponded 
to the biologically active material (fig. 2). These frac- 
tions were combined and evaporated to dryness. The 
residue was dissolved in 1 ml of mixture of methanol- 
water (80:20, v/v), and the solution was applied to a 
column of Sephadex G-25 fine. The elution was per- 
formed with the same solvent. “Compound 259” was 
eluted with fractions 5 l-58 (1 fraction = 20 ml). 
Instead of partition chromatography on a column 
of Sephadex G-25, the precursor compound could be 
purified by thick layer chromatography. The solution 
was spotted quantitatively on a 0.5 mm thick layer of 
Kieselgel HF,, (Merck), and the material was sub- 
jected to chromatography with methanol-water (80:20, 
v/v). Inspection of the chromatogram developed under 
an ultraviolet lamp revealed one strong W-absorbing 
compound (I+, 0.45) and one faint band below the 
strong W absorbing zone. Material at R,- 0.45 was 
eluted from Kieselgel with methanol. Supplementation 
with 0.005 or 0.010 mg thiamine hydrochloride/l 
during cultivation of mutant HK 210 gave similar re- 
sults. However, cells grown in a complete medium [4] 
synthesized during the accumulation period only very 
small amounts of the precursor compound. 
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4. Properties of “compound 259” 
The data indicate that in the biosynthetic pathway 
of the pyrimidine moiety, 2-methylA-amino&hy- 
droxymethyl-pyrimidine is synthesized from 4-amino- 
imidazole ribonucleotide via “compound 259”. The 
W spectrum of the biologically active compound 
showed a maximum at 259 nm, both in 0.1 N HCl and 
0.1 N NaOH. No significant shift was observed in the 
pH range from 1 to 13. 
“Compound 259” is heat stable in aquous olution 
(pH 5-7) at temperatures up to 120”. Therefore it 
was possible to autoclave the precursor compound in 
minimal medium before testing its biological activity. 
However, it loses biological activity after several hr 
in 1 N NaOH at 100”; treatment with 1 N HCl at 100” 
converted the precursor compound to a biologically 
inactive substance. with an altered spectroscopic and 
chromatographic behaviour. The maximum of the UV 
spectrum shifted from 259 nm to 26 1 nm (in 0.1 N 
HCl) and approximately 268 nm (in 0.1 N NaOH), 
respectively. The Rf value of the derivative in the 
above solvent system was 0.66. 
The NMR spectrum of purified “compound 259” 
in 40 shows a singulett at 6 = 2.00 ppm (rel. int. 3), 
a dublett at S = 6.15 ppm (rel. int. 2) and a triplett at 
6 = 8.5 ppm (rel. int. 3, TMS, extern). The singulett 
corresponding to the methyl group in 2-methyl-4- 
aminod-hydroxymethyl-pyrimidine was found at 
6 = 2.67 ppm. From the shifted signal one may draw 
the conclusion that the methyl group in “compound 
259” is bound at a double bond, probably 
H&-d = N-, but not at an aromatic ring system. 
Elution of “compound 259” is retarded by the same 
degree on Sephadex G-10 in the solvent systems 0.5 N 
acetic acid and 0.5 N ammonia, respectively. From 
this it may be concluded, that if “compound 259” 
has a ring structure, it is not yet a completely unsat- 
urated 4-amino-pyrimidine system. This is supported 
by the W spectrum. 
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